Local News Cyrus Biotechnology Announces $18M Financing and Acquisition of Orthogonal Biologics to Form an Integrated Software-Driven Pre-Clinical-Stage Drug Discovery FirmCyrus Biotechnology | December 8, 2021Cyrus Biotechnology, Inc., a Seattle-based biotechnology firm with a proprietary software platform for biologics discovery,…dcorriganDecember 8, 2021 Read More
Local News Science Says: Fearless ScienceFred Hutch | December 7, 2021Timid research doesn't save lives. On Nov. 30, Fred Hutchinson Cancer Research Center brought several…dcorriganDecember 7, 2021 Read More
Local News Inherited Mutation Linked to Aggressive Prostate CancerUW Medicine | December 7, 2021Men who inherit mutations in a gene called TP53 have a high risk of developing aggressive prostate…dcorriganDecember 7, 2021 Read More
Local News Tune Therapeutics Launches with $40M in Funding, Aims to Fine-Tune Activity of Genes in CellsGeekWire | December 7, 2021A new biotech startup with operations in Seattle and Durham, N.C., has launched with $40…dcorriganDecember 7, 2021 Read More
Local News Dr. Christopher Li named associate director of Diversity, Equity and Inclusion for Fred Hutch/UW Cancer ConsortiumFred Hutch | December 6, 2021The Fred Hutch/University of Washington Cancer Consortium has named Dr. Christopher Li its first associate director of…dcorriganDecember 6, 2021 Read More
Local News COVID-19 Experts Answer Questions about Omicron — and Where the Variant May Have Come FromGeekWire | December 3, 2021There’s not a lot known about the new COVID-19 variant Omicron, but what scientists see…dcorriganDecember 3, 2021 Read More
Local News Dr. Robert Bradley Named Scientific Director of Fred Hutch Translational Data Science Integrated Research CenterFred Hutch | December 3, 2021On Dec. 1, Fred Hutchinson Cancer Research Center named computational biologist Dr. Robert Bradley scientific director of…dcorriganDecember 3, 2021 Read More
Local News Visus Therapeutics Announces Positive Topline Clinical Data from Phase II VIVID Study of BRIMOCHOL for the Treatment of PresbyopiaVisus Therapeutics | December 2, 2021Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve…dcorriganDecember 2, 2021 Read More
Local News Chinook Therapeutics Announces Formation Of Sanreno Therapeutics, A Joint Venture To Develop Kidney Disease Therapies In ChinaChinook Therapeutics | December 2, 2021Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of…dcorriganDecember 2, 2021 Read More
Local News What Hutch Coronavirus Experts Are Saying about OmicronFred Hutch | December 1, 2021Another Greek letter has entered the vernacular. In late November, the World Health Organization designated SARS-CoV-2…dcorriganDecember 1, 2021 Read More